Enovix Corporation (NASDAQ:ENVX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Enovix Corporation (NASDAQ:ENVX) have received an average rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $12.6364.

ENVX has been the subject of a number of analyst reports. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Oppenheimer decreased their price objective on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. B. Riley Financial decreased their price objective on shares of Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, March 2nd. TD Cowen reaffirmed a “buy” rating on shares of Enovix in a report on Thursday, May 14th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Friday, April 10th.

Enovix Stock Performance

Shares of ENVX opened at $6.36 on Friday. The firm has a 50-day moving average of $5.88 and a 200-day moving average of $6.95. Enovix has a one year low of $4.61 and a one year high of $16.49. The company has a market cap of $1.39 billion, a PE ratio of -7.66 and a beta of 2.24. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The company had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. During the same quarter last year, the firm posted ($0.15) EPS. The company’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities analysts forecast that Enovix will post -0.81 earnings per share for the current year.

Institutional Investors Weigh In On Enovix

Hedge funds have recently bought and sold shares of the stock. Caitlin John LLC acquired a new stake in Enovix during the third quarter worth approximately $27,000. Parallel Advisors LLC lifted its position in Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Enovix during the fourth quarter worth approximately $30,000. CWM LLC lifted its position in Enovix by 95.4% during the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after acquiring an additional 2,969 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Enovix during the third quarter worth approximately $80,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.